Dr Georg Buchner has over 10 years’ experience in Business and Corporate development. He has worked with various biotech companies in the UK and was Amgen’s Business Development Director covering the UK, Scandinavia and Israel. His deal experiences range from M&A (the sale of Haptogen to Wyeth in 2005), VC funding and technology/product licencing at every development stage. Georg has an MBA in biotechnology from Cambridge University.
